Inaktiver Wert

Cornerstone Therapeutics, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	28.02.14
Cornerstone Therapeutics Inc. Stockholders Approve Merger	03.02.14
Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	01.02.14
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	20.11.13
Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	31.10.13

Sektor

	% 1. Jan.	Kap.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19,62 %	43,27 Mrd.
OTSUKA HOLDINGS CO., LTD.	+24,52 %	22,92 Mrd.
SANDOZ GROUP AG	+20,29 %	15,43 Mrd.
CIPLA LIMITED	+7,48 %	12,95 Mrd.
ZYDUS LIFESCIENCES LIMITED	+42,51 %	11,83 Mrd.
ONO PHARMACEUTICAL CO., LTD.	-8,84 %	6,91 Mrd.
THE MEDICINES COMPANY	-0,05 %	6,79 Mrd.
STADA ARZNEIMITTEL	-8,87 %	5,73 Mrd.
ASPEN PHARMACARE HOLDINGS LIMITED	+13,13 %	5,55 Mrd.